BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Chuan-Lin Ding, Kun Yao, Tian-Tai Zhang, Feng Zhou, Lin Xu, Jiang-Ying Xu. Generation of cytotoxic T cell against HBcAg using retrovirally transduced dendritic cellsWorld Journal of Gastroenterology 2003; 9(7): 1512-1515 doi: 10.3748/wjg.v9.i7.1512
2
De-Wei Du, Zhan-Sheng Jia, Guang-Yu Li, Yong-Ying Zhou. HBV DNA vaccine with adjuvant cytokines induced specific immune responses against HBV infectionWorld Journal of Gastroenterology 2003; 9(1): 108-111 doi: 10.3748/wjg.v9.i1.108
3
Erica L. Woodahl, Rodney J. Y. Ho. Cellular Drug Delivery2004; : 45 doi: 10.1007/978-1-59259-745-1_4
4
Åsa Schiött, Kristina Larsson, Søren Manniche, Suzanne Kalliomäki, Annette Vinther Heydenreich, Kristian Dalsgaard, Nikolai Kirkby. Posintro™-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responsesInternational Journal of Pharmaceutics 2011; 414(1-2): 312 doi: 10.1016/j.ijpharm.2011.05.026
5
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Wei Zhou, Li-Yun Zou. Therapeutic polypeptides based on HBcAg<sub>18-27</sub> CTL epitope can induce antigen-specific CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2 transgenic miceWorld Journal of Gastroenterology 2004; 10(8): 1222-1226 doi: 10.3748/wjg.v10.i8.1222
6
Tong-Dong Shi, Yu-Zhang Wu, Zheng-Cai Jia, Li-Yun Zou, Wei Zhou. Therapeutic polypeptides based on HBV core 18-27 epitope can induce CD<sub>8</sub><sup>+</sup> CTL-mediated cytotoxicity in HLA-A2<sup>+</sup> human PBMCsWorld Journal of Gastroenterology 2004; 10(13): 1902-1906 doi: 10.3748/wjg.v10.i13.1902
7
Hong Cheng, Hui-Zhong Zhang, Wan-An Shen, Yan-Fang Liu, Fu-Cheng Ma. Expression of RNase H of human hepatitis B virus polymerase in <italic>Escherichia coli</italic>World Journal of Gastroenterology 2003; 9(3): 513-515 doi: 10.3748/wjg.v9.i3.513
8
Megan T Sanders, Lorena E Brown, Georgia Deliyannis, Martin J Pearse. ISCOMTM -based vaccines: The second decadeImmunology and Cell Biology 2005; 83(2): 119 doi: 10.1111/j.1440-1711.2005.01319.x
9
Rishi Paliwal, Shivani R Paliwal, Suresh P Vyas. Advances in effective vaccine development against hepatitis B: focus on mucosal vaccine delivery strategiesTherapeutic Delivery 2010; 1(3): 397 doi: 10.4155/tde.10.19
10
Chang-Zheng Song, Qing-Wei Wang, Chang-Cheng Song, Zeng-Liang Bai. Viral replication modulated by synthetic peptide derived from hepatitis B virus X proteinWorld Journal of Gastroenterology 2004; 10(3): 389-392 doi: 10.3748/wjg.v10.i3.389